A federal court has ruled that terminally ill patients do not have a right to experimental drugs that have not been FDA approved. The plaintiff asked that the FDA approve experimental medications that have passed safety trials but have not been sufficiently proven safe and effective. The plaintiffs based this inquiry off of what they believe to be the constitutional right of self preservation. Terminally ill patients might have no FDA approved treatment options and experimental medications could be their only chance at survival. The FDA said that the risks of harm of unapproved drugs is too great, even in cases of the terminally ill. The appeals court ruled in the FDA’s favor and suggested that advocates of experimental drugs approach the legislature.